Search Result "Asymmetric Dimethylarginine"


The Association between Serum Asymmetric Dimethylarginine and Coronary Atherosclerotic Plaque in an Asymptomatic Population

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 12 Issue: 3 Year: 2012 Page: 236-243
Author(s): Chun-Yao Huang,Jong-Shiuan Yeh,Chun-Ming Shih,Feng-Yen Lin,Yung-Ta Kao,Nai-Wen Tsao,Wen-Tien Hsiao,Jaw-Wen Chen,Nen-Chung Chang,Kou-Gi Shyu

Review Article

Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?

Journal: Current Pharmaceutical Design
Volume: 27 Issue: 1 Year: 2021 Page: 2131-2140
Author(s): Arduino A. Mangoni,Sara Tommasi,Salvatore Sotgia,Angelo Zinellu,Panagiotis Paliogiannis,Matteo Piga,Alberto Cauli,Gianfranco Pintus,Ciriaco Carru,Gian L. Erre

Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?

Journal: Current Topics in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2013 Page: 180-200
Author(s): Georgios Bouras, Spyridon Deftereos, Dimitrios Tousoulis, Georgios Giannopoulos, Georgios Chatzis, Dimitrios Tsounis, Michael W. Cleman, Christodoulos Stefanadis

Asymmetrical Dimethyl Arginine, Nitric Oxide, and Type 2 Diabetes

Ebook: The Role of Nitric Oxide in Type 2 Diabetes

Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815079814122010007

The Biology and Therapeutic Potential of the DDAH/ADMA Pathway

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 4089-4102
Author(s): F. Arrigoni, B. Ahmetaj, J. Leiper

The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 90-97
Author(s): Aleksandra Szlachcic,Gracjana Krzysiek-Maczka,Robert Pajdo,Aneta Targosz,Marcin Magierowski,Katarzyna Jasnos,Danuta Drozdowicz,Slawomir Kwiecien,Tomasz Brzozowski

Research Article

Pharmacology and Clinical Pharmacology of Methylarginines Used as Inhibitors of Nitric Oxide Synthases

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 22 Year: 2014 Page: 3530-3547
Author(s): Anja Kittel,Renke Maas

High Glucose-Mediated Imbalance of Nitric Oxide Synthase and Dimethylarginine Dimethylaminohydrolase Expression in Endothelial Cells

Journal: Current Neurovascular Research
Volume: 3 Issue: 1 Year: 2006 Page: 49-54
Author(s): Valeria Sorrenti, Francesco Mazza, Agata Campisi, Luca Vanella, Giovanni Li Volti, Claudia Di Giacomo

Cardiovascular Tests: Use & Limits of Biochemical Markers - Therapeutic Measurements of ADMA Involved in Cardiovascular Disorders

Journal: Current Pharmaceutical Design
Volume: 11 Issue: 1 Year: 2005 Page: 2177-2185
Author(s): Caroline L. Smith, Patrick Vallance

Clinical Utility of Biomarkers in Premature Atherosclerosis

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 16 Year: 2012 Page: 2521-2533
Author(s): A.-M. Kampoli,D. Tousoulis,N. Papageorgiou,Z. Pallatza,G. Vogiatzi,A. Briasoulis,E. Androulakis,C. Toutouzas,P. Stougianos,C. Tentolouris,C. Stefanadis

Previous   Next

Go To   Results 11 - 20 of 343

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy